Gene · 4633
Papers3,564
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 3,564
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Preclinical models for development of immune-oncology therapies. | Immuno-oncol Insights | 2022 | 37132013 | PubTator, text mining | PubMed |
| Spatiotemporal transcriptomics reveals pathogenesis of viral myocarditis. | Nat Cardiovasc Res | 2022 | 36970396 | PubTator, text mining | PubMed |
| Corrigendum: Genetic inactivation of Chlamydia trachomatis inclusion membrane protein CT228 alters MYPT1 recruitment, extrusion production, and longevity of infection. | Front Cell Infect Microbiol | 2022 | 36865595 | PubTator, text mining | PubMed |
| Human-gained heart enhancers are associated with species-specific cardiac attributes. | Nat Cardiovasc Res | 2022 | 36817700 | PubTator, text mining | PubMed |
| Implications of S-glutathionylation of sarcomere proteins in cardiac disorders, therapies, and diagnosis. | Front Cardiovasc Med | 2022 | 36762302 | PubTator, text mining | PubMed |
| Cardiac calcium regulation in human induced pluripotent stem cell cardiomyocytes: Implications for disease modeling and maturation. | Front Cell Dev Biol | 2022 | 36742199 | PubTator, text mining | PubMed |
| The Role of Single-Cell Profiling and Deep Immunophenotyping in Understanding Immune Therapy Cardiotoxicity. | JACC CardioOncol | 2022 | 36636436 | PubTator, text mining | PubMed |
| Molecular Diagnosis of Hypertrophic Cardiomyopathy (HCM): In the Heart of Cardiac Disease. | J Clin Med | 2022 | 36615026 | PubTator, text mining | PubMed |
| De Novo Asp219Val Mutation in Cardiac Tropomyosin Associated with Hypertrophic Cardiomyopathy. | Int J Mol Sci | 2022 | 36613463 | PubTator, text mining | PubMed |
| Severe hypertrophic cardiomyopathy in a patient with a homozygous MYH7 gene variant. | Heliyon | 2022 | 36593836 | PubTator, text mining | PubMed |
| The Development of an Infrastructure to Facilitate the Use of Whole Genome Sequencing for Population Health. | J Pers Med | 2022 | 36579594 | PubTator, text mining | PubMed |
| Biology-inspired data-driven quality control for scientific discovery in single-cell transcriptomics. | Genome Biol | 2022 | 36575523 | PubTator, text mining | PubMed |
| Single-cell transcriptomic analysis identifies murine heart molecular features at embryonic and neonatal stages. | Nat Commun | 2022 | 36575170 | PubTator, text mining | PubMed |
| Integrative single-cell analysis of cardiogenesis identifies developmental trajectories and non-coding mutations in congenital heart disease. | Cell | 2022 | 36563664 | PubTator, text mining | PubMed |
| Preclinical evaluation of the ROCK1 inhibitor, GSK269962A, in acute myeloid leukemia. | Front Pharmacol | 2022 | 36561342 | PubTator, text mining | PubMed |
| Real-World Results from Combined Screening for Monogenic Genomic Health Risks and Reproductive Risks in 300 Adults. | J Pers Med | 2022 | 36556183 | PubTator, text mining | PubMed |
| Cardiac Sarcomere Signaling in Health and Disease. | Int J Mol Sci | 2022 | 36555864 | PubTator, text mining | PubMed |
| Therapeutic Potential of Mesenchymal Stem Cells in the Treatment of Epilepsy and Their Interaction with Antiseizure Medications. | Cells | 2022 | 36552892 | PubTator, text mining | PubMed |
| Increased MARCKS Activity in BRAF Inhibitor-Resistant Melanoma Cells Is Essential for Their Enhanced Metastatic Behavior Independent of Elevated WNT5A and IL-6 Signaling. | Cancers (Basel) | 2022 | 36551563 | PubTator, text mining | PubMed |
| Differentiating Human Pluripotent Stem Cells to Cardiomyocytes Using Purified Extracellular Matrix Proteins. | Bioengineering (Basel) | 2022 | 36550926 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4633/papers?page=26